Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 1/2019

21.06.2018 | Original Article

Identification of novel variants in neonatal diabetes mellitus genes in Egyptian patients with permanent NDM

verfasst von: Hanan Madani, Rasha Elkaffas, Badawy Alkholy, Noha Musa, Yomna Shaalan, Rania Elkaffas, Mona Hassan, Mona Hafez, Sarah E Flanagan, Elisa De Franco, Khalid Hussain

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes resulting from mutations in more than 20 different genes encoding proteins playing a key role in the normal function of the pancreatic beta-cell. Mutations in the genes encoding the ATP-sensitive potassium channel, ABCC8, and KCNJ11 and insulin (INS) gene are the most common causes of NDM; however, in consanguineous populations, EIF2AK3 mutations are more common. Identification of the causative mutations by genetic testing is critical for appropriate management and to guide genetic counseling. To determine the genetic etiology of NDM in diabetic neonates and infants diagnosed before the age of 1 year and to describe their phenotype/genotype characteristics, DNA sequencing of coding regions and intronic boundaries of ABCC8, KCNJ11, INS, and EIF2AK3 genes was undertaken in 20 patients. Further, targeted next-generation sequencing was performed for other genes known to cause NDM. ABCC8 mutations were found in two patients (10%), with compound heterozygous mutations (p.N131 K/p.R598*) in one patient and a homozygous mutation (p.R1554Q) in the another patient. Heterozygous p.A174G and p.V59M mutations of KCNJ11 were identified in two patients (10%), and homozygous EIF2AK3 mutations were identified in two further patients (p.T905fs and p.R653T) (10%). No INS mutations were identified. Further testing identified a SLC19A2 mutation (p.W387*) in one patient (5%) and the same homozygous GCK mutation in two siblings (p.A188T). ABCC8, KCNJ11, and EIF2AK3 mutations were the main genetic causes of permanent NDM among Egyptian neonates.
Literatur
1.
Zurück zum Zitat Carmody D, Støy J, Greeley SA, Bell GI, Philipson LH. A clinical guide to monogenic diabetes. In: Weiss RE, Refetoff S, editors. Genetic diagnosis of endocrine Disorders. 2nd ed. Philadelphia, PA: Elsevier; 2016. p. 19–30. Carmody D, Støy J, Greeley SA, Bell GI, Philipson LH. A clinical guide to monogenic diabetes. In: Weiss RE, Refetoff S, editors. Genetic diagnosis of endocrine Disorders. 2nd ed. Philadelphia, PA: Elsevier; 2016. p. 19–30.
2.
Zurück zum Zitat Ellard S, Lango Allen H, de Franco E, Flanagan SE, Hysenaj G, Colclough K, et al. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia. 2013;56:1958–63.CrossRefPubMedPubMedCentral Ellard S, Lango Allen H, de Franco E, Flanagan SE, Hysenaj G, Colclough K, et al. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia. 2013;56:1958–63.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat De Franco E, et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 2015;386:957–63.CrossRefPubMedPubMedCentral De Franco E, et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 2015;386:957–63.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008;4:200–13.CrossRefPubMed Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008;4:200–13.CrossRefPubMed
5.
Zurück zum Zitat Njolstad PR, et al. Permanent neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med. 2001;344:1588–92.CrossRefPubMed Njolstad PR, et al. Permanent neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med. 2001;344:1588–92.CrossRefPubMed
6.
Zurück zum Zitat Onal H, et al. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness. Turk J Pediatr. 2009;51(3):301–4.PubMed Onal H, et al. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness. Turk J Pediatr. 2009;51(3):301–4.PubMed
7.
Zurück zum Zitat Greeley SA, Tucker SE, Naylor RN, Bell GI, Philipson H. Neonatal diabetes mellitus: a model for personalized medicine. NIH Public Access. 2011;21(8):464–72. Greeley SA, Tucker SE, Naylor RN, Bell GI, Philipson H. Neonatal diabetes mellitus: a model for personalized medicine. NIH Public Access. 2011;21(8):464–72.
8.
Zurück zum Zitat Rubio-Cabezas O, Patch AM, Minton JA, Flanagan SE, Edghill EL, Hussain K, et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab. 2009;94(11):4162–70.CrossRefPubMedPubMedCentral Rubio-Cabezas O, Patch AM, Minton JA, Flanagan SE, Edghill EL, Hussain K, et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab. 2009;94(11):4162–70.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006;355:467–77.CrossRefPubMed Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006;355:467–77.CrossRefPubMed
10.
Zurück zum Zitat American Diabetes Association(ADA). Standards of medical care in diabetes. Diabetes Care. 2013;36(1):S11–66.CrossRef American Diabetes Association(ADA). Standards of medical care in diabetes. Diabetes Care. 2013;36(1):S11–66.CrossRef
11.
Zurück zum Zitat Ellard S, Flanagan SE, Girard CA, Patch AM, Harries LW, Parrish A, et al. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet. 2007;81(2):375–82.CrossRefPubMedPubMedCentral Ellard S, Flanagan SE, Girard CA, Patch AM, Harries LW, Parrish A, et al. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet. 2007;81(2):375–82.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Klupa T, Edghill EL, Nazim J, Sieradzki J, Ellard S, Hattersley AT, et al. The identification of a R201H mutation in KCNJ11 which encodes Kir 6.2, and successful transfer to sustained release sulfonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation. Diabetologia. 2005;48(5):1029–31.CrossRefPubMed Klupa T, Edghill EL, Nazim J, Sieradzki J, Ellard S, Hattersley AT, et al. The identification of a R201H mutation in KCNJ11 which encodes Kir 6.2, and successful transfer to sustained release sulfonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation. Diabetologia. 2005;48(5):1029–31.CrossRefPubMed
13.
Zurück zum Zitat Moritani M, Yokota I, Tsubouchi K, Takaya R, Takemoto K, Minamitani K, et al. Identification of INS and KCNJ11 gene mutations in type 1B diabetes in Japanese children with onset of diabetes before 5 years of age. Pediatr Diabetes. 2013;14(2):112–20.CrossRefPubMed Moritani M, Yokota I, Tsubouchi K, Takaya R, Takemoto K, Minamitani K, et al. Identification of INS and KCNJ11 gene mutations in type 1B diabetes in Japanese children with onset of diabetes before 5 years of age. Pediatr Diabetes. 2013;14(2):112–20.CrossRefPubMed
14.
Zurück zum Zitat Rubio-Cabezas O, Hattersley AT, Njølstad PR, Mlynarski W, Ellard S, White N, et al. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2014;15(20):47–64.CrossRefPubMed Rubio-Cabezas O, Hattersley AT, Njølstad PR, Mlynarski W, Ellard S, White N, et al. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2014;15(20):47–64.CrossRefPubMed
15.
Zurück zum Zitat Rubio-Cabezas O, Flanagan SE, Damhuis A, Hattersley AT, Ellard S. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life. Pediatr Diabetes. 2012;13:322–5.CrossRefPubMed Rubio-Cabezas O, Flanagan SE, Damhuis A, Hattersley AT, Ellard S. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life. Pediatr Diabetes. 2012;13:322–5.CrossRefPubMed
16.
Zurück zum Zitat Mohnike K, Wieland I, Barthlen W, Vogelgesang S, Empting S, Mohnike W, et al. Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism. Horm Res Pediatr. 2014;81(3):156–68.CrossRef Mohnike K, Wieland I, Barthlen W, Vogelgesang S, Empting S, Mohnike W, et al. Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism. Horm Res Pediatr. 2014;81(3):156–68.CrossRef
17.
Zurück zum Zitat Suzuki S, Makita Y, Mukai T, Matsuo K, Ueda O, Fujieda K. Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab. 2007;92:3979–85.CrossRefPubMed Suzuki S, Makita Y, Mukai T, Matsuo K, Ueda O, Fujieda K. Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab. 2007;92:3979–85.CrossRefPubMed
18.
Zurück zum Zitat Temple IK, Shield JP. 6q24 transient neonatal diabetes. Rev Endocr Metab Disord. 2010;11(3):199–204.CrossRefPubMed Temple IK, Shield JP. 6q24 transient neonatal diabetes. Rev Endocr Metab Disord. 2010;11(3):199–204.CrossRefPubMed
19.
Zurück zum Zitat Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004;350(18):1838–49.CrossRefPubMed Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004;350(18):1838–49.CrossRefPubMed
20.
Zurück zum Zitat Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes. 2005;54(9):2503–13.CrossRefPubMed Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes. 2005;54(9):2503–13.CrossRefPubMed
21.
Zurück zum Zitat Madani HA, Fawzy N, Afif S, Abdelghaffar S, Gohar N. Study of KCNJ11 gene mutations in association with monogenic diabetes of infancy and response to sulfonylurea treatment in a cohort study in Egypt. Acta Endocrinologica (Buc). 2016;XII(2):157–60.CrossRef Madani HA, Fawzy N, Afif S, Abdelghaffar S, Gohar N. Study of KCNJ11 gene mutations in association with monogenic diabetes of infancy and response to sulfonylurea treatment in a cohort study in Egypt. Acta Endocrinologica (Buc). 2016;XII(2):157–60.CrossRef
22.
Zurück zum Zitat Banka S, de Goede C, Yue WW, Morris AAM, von Bremen B, Chandler KE, et al. Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. Mol Genet Metab. 2014;113(4):301–6.CrossRefPubMed Banka S, de Goede C, Yue WW, Morris AAM, von Bremen B, Chandler KE, et al. Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. Mol Genet Metab. 2014;113(4):301–6.CrossRefPubMed
23.
Zurück zum Zitat Mikstiene V, Songailiene J, Byckova J, Rutkauskiene G, Jasinskiene E, Verkauskiene R, et al. Thiamine responsive megaloblastic anaemia syndrome: a novel homozygous SLC19A2gene mutation identified. Am J Med Genet A. 2015;167(7):1605–9.CrossRefPubMed Mikstiene V, Songailiene J, Byckova J, Rutkauskiene G, Jasinskiene E, Verkauskiene R, et al. Thiamine responsive megaloblastic anaemia syndrome: a novel homozygous SLC19A2gene mutation identified. Am J Med Genet A. 2015;167(7):1605–9.CrossRefPubMed
24.
Zurück zum Zitat Aycan Z, Baş VN, Çetinkaya S, Ağladioğlu SY, Kendirci HNP, Şenocak F. Thiamine-responsive megaloblastic anemia syndrome with atrial standstill: a case report. J Pediatr Hematol Oncol. 2011;33(2):144–7.CrossRefPubMed Aycan Z, Baş VN, Çetinkaya S, Ağladioğlu SY, Kendirci HNP, Şenocak F. Thiamine-responsive megaloblastic anemia syndrome with atrial standstill: a case report. J Pediatr Hematol Oncol. 2011;33(2):144–7.CrossRefPubMed
25.
Zurück zum Zitat Rubio-Cabezas O, Klupa T, Malecki MT, CEED3 Consortium. Permanent neonatal diabetes mellitus-the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Investig. 2011;41(3):323–33.CrossRef Rubio-Cabezas O, Klupa T, Malecki MT, CEED3 Consortium. Permanent neonatal diabetes mellitus-the importance of diabetes differential diagnosis in neonates and infants. Eur J Clin Investig. 2011;41(3):323–33.CrossRef
26.
Zurück zum Zitat Thomson, et al. Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY). Hum Mutat. 2003;22:417–22.CrossRefPubMed Thomson, et al. Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY). Hum Mutat. 2003;22:417–22.CrossRefPubMed
Metadaten
Titel
Identification of novel variants in neonatal diabetes mellitus genes in Egyptian patients with permanent NDM
verfasst von
Hanan Madani
Rasha Elkaffas
Badawy Alkholy
Noha Musa
Yomna Shaalan
Rania Elkaffas
Mona Hassan
Mona Hafez
Sarah E Flanagan
Elisa De Franco
Khalid Hussain
Publikationsdatum
21.06.2018
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 1/2019
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-018-0658-6

Weitere Artikel der Ausgabe 1/2019

International Journal of Diabetes in Developing Countries 1/2019 Zur Ausgabe